Medical and Pharmaceutical Plastic Waste

Medical and pharmaceutical plastic waste is the ninth-largest source of plastic pollution, driven by a staggering 8 million additional tonnes from the COVID-19 pandemic alone. Hospitals now generate 25% more single-use plastic than pre-pandemic levels, with masks, gloves, and test kits accounting for the bulk of the surge. This sector's reliance on disposable safety gear, required for infection control, creates a unique challenge: these items are rarely recycled due to contamination risks and often end up incinerated or landfilled. Outperforming #10 (E-Commerce Packaging Explosion) in sheer volume per capita, medical waste inflicts a heavier environmental cost per tonne because it is more likely to contain hazardous materials. For example, a single tonne of medical plastic waste carries 35% more toxic residue than the average plastic waste tonne, as per a 2022 study. Yet innovations like reusable surgical gowns and biodegradable syringes are gaining traction, potentially cutting waste by 40% if adopted widely. Without systemic redesign, this category will continue to grow, outpacing the average waste stream increase of 3% annually.